LDI (short for low-dose immunotherapy) works by helping the immune system restore proper balance by reducing inflammation caused by pathogens (bacteria, viruses, parasites, etc.) LDI has been shown to provide dramatic relief of symptoms and improvement in health for patients with a wide range of chronic illnesses.
Most autoimmune diseases are triggered by an initial infection. As the immune system fights the infection, it may begin to confuse the body’s own proteins with proteins made by foreign invaders such as bacteria and viruses. Even after the pathogens have been eliminated, the immune system remains activated, and an autoimmune reaction triggered by the pathogens has been launched.
LDI combines specific antigens which can be administered by intradermal injection or by sublingual dosing. The effect is calming the abnormally activated immune system and in turn reducing the negative effects of an improper overactive immune system. Each dose of LDI is customized to the patient based on the symptoms and the health condition they are in. Some patients can experience immediate symptom relief within days, and can last for several weeks.
Low-dose immunotherapy has proven to be a safe and effective treatment for many chronic illnesses that previously had no effective treatment options, or which were often treated with harmful prescription medications.